News

Lupaka Gold Secures Arbitration Award Against Peru for Investment

Lupaka Gold Secures Arbitration Award Against Peru for Investment

Exciting Arbitration Claim Developments

Lupaka Gold Corp. is thrilled to share significant news regarding its arbitration case against the Republic of Peru. Recently, the company received a Final Award from the Arbitral Tribunal concerning violations of the Free Trade Agreement between Canada and Peru. This pertains to Lupaka's investments in the Invicta Gold Project, highlighting the ongoing commitment to safeguard shareholder interests and legal rights.

Tribunal's Decision and Financial Implications

The Arbitral Tribunal has upheld Lupaka's claims, ruling that Peru is obligated to compensate the company approximately US$65 million. This amount includes:

1. **Compensation of US$40,400,000**: This full claim amount is subject to compounded interest, reflecting financial burdens that have been incurred since August 2019. The specified rates will apply until the final payment is made, ensuring that Lupaka is justly compensated for the delays.

2. **Reimbursement of Arbitration Costs**: Additionally, the Tribunal has mandated repayment of US$4,215,956.42 for the expenses related to the arbitration process. This amount will also accrue interest from the award date until the payments are concluded, further recognizing the financial impact of this prolonged situation.

CEO's Insights on the Award

Gordon Ellis, the CEO of Lupaka, expressed optimism about the recent ruling. He emphasized that while this award is a successful milestone, it is crucial to acknowledge that the company may face additional challenges before receiving any payments. Ellis noted that navigating through further procedural steps is standard in complex arbitration cases like this one.

Next Steps and Shareholder Engagement

As the situation unfolds, Lupaka is actively collaborating with legal advisors to define the best course of action moving forward. The company aims to keep its shareholders apprised of all developments related to this arbitration. Ellis confirmed that any initial payments following the receipt of the awarded funds will be directed to their funding partner, Benchwalk LP, reinforcing their shared commitment to the case.

Staying Informed on Arbitration Updates

For more details regarding the arbitration proceedings and potential future updates, shareholders and interested parties are encouraged to visit the company’s website. Continuous updates will provide transparency and ensure stakeholders are well-informed about significant advancements in this matter.

Company Support in Legal Proceedings

Lupaka is being represented in these proceedings by the international law firm LALIVE. Renowned for its expertise in international dispute resolution, LALIVE has a proven history in investment arbitration cases, particularly in the mining sector. Their extensive experience is expected to be beneficial throughout the arbitration process.

Financial Backing from Bench Walk Advisors

The case is also supported by Bench Walk Advisors, a prominent litigation financier. With over USD 250 million invested in various commercial cases, Bench Walk's involvement adds considerable stability to Lupaka's ongoing efforts in arbitration. Their reputation in the legal funding industry complements Lupaka’s strategic objectives.

About Lupaka Gold

Lupaka Gold Corp. is dedicated to enhancing shareholder value through diligent identification and development of valuable mining assets. The company remains focused on growth and successful project management.

Contact Information

For further inquiries, please reach out to:

Gordon Ellis, CEO
Email: gellis@lupakagold.com
Tel: (604) 985-3147

Frequently Asked Questions

What is the recent arbitration award received by Lupaka Gold?

Lupaka Gold received a Final Award from the Arbitral Tribunal, mandating Peru to pay approximately US$65 million for claims related to the Invicta Gold Project.

Who represented Lupaka Gold in the arbitration proceedings?

Lupaka Gold is represented by LALIVE, an international law firm specializing in international investment arbitration.

What are the next steps for Lupaka following the award?

The company is currently in discussions with legal counsel to determine the best way to proceed and navigate the collection of awarded funds.

How can I get updates on Lupaka Gold's arbitration status?

Shareholders and interested parties can visit Lupaka's website for ongoing updates and information regarding their arbitration case.

What role does Bench Walk Advisors play in this situation?

Bench Walk Advisors provides litigation financing support, allowing Lupaka Gold to manage costs associated with the arbitration proceedings effectively.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Investors Urged to Act as Lawsuit Against Everus Builds

Updated Category News Views 97

Investigation of Claims Against Everus Construction Group Faruqi & Faruqi, LLP, a well-respected national securities law firm, has initiated an investigation into potential claims associated with Everus Construction Group, Inc. (NYSE: ECG). The firm specializes in shareholder rights and is aiming to provide support to affected investors after concerning revelations about...

Continue Reading
Heilongjiang Forum 2025: Elevating Macao's Global Tourism Standing

Updated Category News Views 107

Global Tourism Economy Forum 2025: A Landmark Event The Global Tourism Economy Forum (GTEF) made its notable debut outside of Macao by hosting the 2025 edition in Heilongjiang province, China. This forum gathered influential figures from the tourism sector and various related industries, fostering discussions aimed at exploring new avenues for cooperation and growth....

Continue Reading
Nextracker and T1 Energy Collaboration Drives Solar Growth

Updated Category News Views 198

Nextracker and T1 Energy Join Forces to Strengthen Solar Production Nextracker Inc. (NASDAQ: NXT) has recently established a partnership with T1 Energy Inc. (NYSE: TE) aimed at revolutionizing solar manufacturing. This collaboration will see the integration of Nextracker's cutting-edge steel module frame technology into T1 Energy's upcoming solar manufacturing plant,...

Continue Reading
Nathan Ballentine Steps In as Regional VP at New American Funding

Updated Category News Views 175

New Leadership at New American Funding New American Funding (NAF), a prominent independent mortgage lender, has announced a significant appointment. Nathan Ballentine is joining the team as the Regional Vice President, where he will play a pivotal role in propelling growth and development within the state. His expertise will be crucial as the company seeks to deepen its...

Continue Reading
CSL Behring Secures Approval for ANDEMBRY® in Japan

Updated Category News Views 341

CSL Behring's Recent Approval for ANDEMBRY® CSL Behring has announced a significant medical milestone with the approval of ANDEMBRY® (garadacimab) subcutaneous (S.C.) injection 200mg pens in Japan. This groundbreaking therapy is a first-in-class monoclonal antibody specifically designed to inhibit activated Factor XII (FXIIa), a crucial initiator in the hereditary...

Continue Reading